The purpose of this network meta-analysis of randomized controlled trials (RCTs) was to compare rank targeted therapies for patients with diffuse large B-cell lymphoma (DLBCL). This study provides the best treatment strategy for DLBCL patients in terms of overall survival, events-free survival, and overall response rate. |